Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Psoriatic Arthritis

NCT07223138 is registered in ClinicalTrials.gov with MoonLake Immunotherapeutics AG as lead sponsor.

NCT NCT07223138
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07223138 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Psoriatic Arthritis
Lead sponsor
MoonLake Immunotherapeutics AG
Phase
Phase 3
Overall status
Enrolling by invitation
Start date
November 13, 2025
Completion date
February 4, 2028
Enrollment
1,560 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

arthritis, psoriatic